Bank of America
VERA icon

Bank of America’s Vera Therapeutics VERA Stock Holding History

Bank of America’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.7M Sell
589,684
-104,635
-15% -$4.51M ﹤0.01% 2237
2025
Q4 		$35.2M Buy
694,319
+203,847
+42% +$7.24M ﹤0.01% 1815
2025
Q3 		$14.3M Buy
490,472
+96,192
+24% +$2.22M ﹤0.01% 2938
2025
Q2 		$9.29M Buy
394,280
+167,264
+74% +$3.76M ﹤0.01% 3289
2025
Q1 		$5.45M Buy
227,016
+196,772
+651% +$6.32M ﹤0.01% 3715
2024
Q4 		$1.28M Sell
30,244
-106,673
-78% -$4.72M ﹤0.01% 4815
2024
Q3 		$6.05M Sell
136,917
-42,995
-24% -$1.63M ﹤0.01% 3560
2024
Q2 		$6.51M Sell
179,912
-20,240
-10% -$803K ﹤0.01% 3372
2024
Q1 		$8.63M Buy
200,152
+161,669
+420% +$5.76M ﹤0.01% 3123
2023
Q4 		$592K Sell
38,483
-56,633
-60% -$719K ﹤0.01% 5372
2023
Q3 		$1.3M Buy
95,116
+84,457
+792% +$1.45M ﹤0.01% 4617
2023
Q2 		$171K Sell
10,659
-77,178
-88% -$697K ﹤0.01% 5940
2023
Q1 		$682K Buy
87,837
+36,161
+70% +$279K ﹤0.01% 5164
2022
Q4 		$1,000K Buy
51,676
+17,279
+50% +$313K ﹤0.01% 4859
2022
Q3 		$733K Buy
34,397
+12,943
+60% +$242K ﹤0.01% 5107
2022
Q2 		$292K Buy
21,454
+5,850
+37% +$102K ﹤0.01% 5825
2022
Q1 		$367K Buy
15,604
+3,697
+31% +$79.5K ﹤0.01% 6040
2021
Q4 		$318K Buy
11,907
+5,386
+83% +$119K ﹤0.01% 6202
2021
Q3 		$113K Buy
6,521
+309
+5% +$5.52K ﹤0.01% 6655
2021
Q2 		$82K Buy
+6,212
New +$96.5K ﹤0.01% 6619

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America's VERA Position: Q1 2026 in Review

Bank of America reduced its Vera Therapeutics (VERA) stake by 15% in Q1 2026, selling an estimated $4.51M and leaving 589,684 shares worth $23.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2237.

Bank of America first reported a position in VERA in Q2 2021 and has held it in 20 quarters since. The position peaked at $35.2M in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Bank of America held 589,684 shares of Vera Therapeutics worth $23.7M as of Q1 2026.
  • Bank of America sold 104,635 Vera Therapeutics shares in Q1 2026, an estimated $4.51M.
  • Vera Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2237 holding.
  • Bank of America first reported a position in Vera Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Bank of America's Vera Therapeutics position peaked at $35.2M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.